Chess, one quick question. I value your input. Are you saying that you think no matter what EVIO as a testing company will not be around long term in this sector? (this includes being sold, changing management, etc) or....do you just not like the niche/sector. For example I do not like the Canadian growers short to mid term and maybe even long term vs extractors, and MSO's in the US. I think the big gains have been made. Cannabis is a commodity. With the exception of CWBHF or CVSI (CBD/HEMP) commodity driven products rely on price, supply/demand obviously too. If I had to bet on one grower it would be ACB just because they are so diversified and they have not sold out to big Pharma or tobacco companies, and have that carrot of a beverage partner looming. I think of them as I do Henry Schein Dental; very steady growth and very diversified products. (I had the honor of working with Henry Schein helping them launch their dental implant back in the mid 90's....Camlog.)
I would find it hard to believe you do not think the testing companies (EVIO is the only public company I know of for testing) will have huge growth mid to long term. Personally I am not a big fan of investing in Cannabis other than pick and shovels like IIPR KSHB EVIO NBEV GRWG or GWPH ZYNE in biotech, or CBD extractors like MEDIF NEPT VGWCF or the MSOs i mentioned in another post. I think the testing sector is going to be huge and EVIO is the only publicly traded stock that is strictly testing, in this sector (correct me if I am wrong) Really curious to hear your thoughts, as I very much respect your opinion and your respectfulness to others on this board. You call a spade a spade and that is mans game bro.
